Marzia Galli

Marzia Galli is a highly experienced professional in the field of chemistry, currently serving as the DS Launch Lead at Merck Group since September 2017. In this role, Marzia Galli manages late-stage drug substance projects from Phase III and PPQ through to commercial setup and launch, demonstrating expertise in Quality by Design (QbD), validation, and regulatory submissions. Prior experience includes roles as a Researcher and Associate Researcher in drug substance development at Merck Serono, where Marzia Galli focused on synthetic route development, process optimization, and compliance with GMP standards. Marzia Galli's academic background includes a PhD from the University of Southampton, with prior research at Queen Mary, University of London. Educational qualifications also encompass studies at KU Leuven and Sapienza Università di Roma.